{"name":"Centre Leon Berard","slug":"centre-leon-berard","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":9,"colorKey":"oncology","drugs":[{"name":"Imatinib maintenance","genericName":"Imatinib maintenance","slug":"imatinib-maintenance","indication":"Chronic myeloid leukemia (CML) maintenance therapy","status":"phase_3"},{"name":"Imatinib tablets","genericName":"Imatinib tablets","slug":"imatinib-tablets","indication":"Chronic myeloid leukemia","status":"phase_2"},{"name":"BRN01","genericName":"BRN01","slug":"brn01","indication":"Breast cancer, HR-positive, HER2-negative","status":"phase_3"},{"name":"Breast cancer cohort","genericName":"Breast cancer cohort","slug":"breast-cancer-cohort","indication":"Adjuvant treatment of HER2-positive breast cancer","status":"phase_2"},{"name":"Carboplatin AUC7","genericName":"Carboplatin AUC7","slug":"carboplatin-auc7","indication":"Advanced ovarian cancer","status":"phase_2"},{"name":"Firmagon","genericName":"Firmagon","slug":"firmagon","indication":"Advanced Prostatic Carcinoma","status":"marketed"},{"name":"Pazopanib Oral Tablet [Votrient]","genericName":"Pazopanib Oral Tablet [Votrient]","slug":"pazopanib-oral-tablet-votrient","indication":"Soft tissue sarcoma","status":"phase_3"},{"name":"VEC","genericName":"VEC","slug":"vec","indication":"Colorectal cancer (advanced or metastatic)","status":"marketed"},{"name":"interruption of Glivec®","genericName":"interruption of Glivec®","slug":"interruption-of-glivec","indication":"Chronic myeloid leukemia","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"immunology","drugs":[{"name":"Pexa-Vec","genericName":"Pexa-Vec","slug":"pexa-vec","indication":"Other","status":"phase_1"},{"name":"Cocculine®","genericName":"Cocculine®","slug":"cocculine","indication":"Motion sickness-related nausea and vomiting","status":"phase_3"},{"name":"NP137 DL and RP2D","genericName":"NP137 DL and RP2D","slug":"np137-dl-and-rp2d","indication":"Other","status":"phase_1"},{"name":"Placebo of AFATINIB","genericName":"Placebo of AFATINIB","slug":"placebo-of-afatinib","indication":"Other","status":"phase_3"},{"name":"Vesanoid","genericName":"Vesanoid","slug":"vesanoid","indication":"Other","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Injection of Filgrastim","genericName":"Injection of Filgrastim","slug":"injection-of-filgrastim","indication":"Reducing the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy","status":"phase_2"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"neuroscience","drugs":[{"name":"cicaderma + simple hygiene rules","genericName":"cicaderma + simple hygiene rules","slug":"cicaderma-simple-hygiene-rules","indication":"Treatment of dry skin and wound healing","status":"phase_3"}]}],"pipeline":[{"name":"Imatinib maintenance","genericName":"Imatinib maintenance","slug":"imatinib-maintenance","phase":"phase_3","mechanism":"Imatinib is a tyrosine kinase inhibitor that blocks BCR-ABL and other oncogenic kinases to prevent cancer cell proliferation.","indications":["Chronic myeloid leukemia (CML) maintenance therapy","Gastrointestinal stromal tumor (GIST) maintenance therapy"],"catalyst":""},{"name":"Imatinib tablets","genericName":"Imatinib tablets","slug":"imatinib-tablets","phase":"phase_2","mechanism":"Tyrosine kinase inhibitor","indications":["Chronic myeloid leukemia","Acute lymphoblastic leukemia"],"catalyst":""},{"name":"Pexa-Vec","genericName":"Pexa-Vec","slug":"pexa-vec","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"BRN01","genericName":"BRN01","slug":"brn01","phase":"phase_3","mechanism":"BRN01 is a small molecule targeting the CDK4/6 pathway.","indications":["Breast cancer, HR-positive, HER2-negative"],"catalyst":""},{"name":"Breast cancer cohort","genericName":"Breast cancer cohort","slug":"breast-cancer-cohort","phase":"phase_2","mechanism":"This drug targets the HER2 protein to inhibit cancer cell growth.","indications":["Adjuvant treatment of HER2-positive breast cancer"],"catalyst":""},{"name":"Carboplatin AUC7","genericName":"Carboplatin AUC7","slug":"carboplatin-auc7","phase":"phase_2","mechanism":"Carboplatin works by interfering with DNA replication in cancer cells, leading to cell death.","indications":["Advanced ovarian cancer","Small cell lung cancer","Non-small cell lung cancer"],"catalyst":""},{"name":"Cocculine®","genericName":"Cocculine®","slug":"cocculine","phase":"phase_3","mechanism":"Cocculine is a homeopathic preparation traditionally used to alleviate nausea and motion sickness symptoms.","indications":["Motion sickness-related nausea and vomiting","Travel sickness"],"catalyst":""},{"name":"Firmagon","genericName":"Firmagon","slug":"firmagon","phase":"marketed","mechanism":"Gonadotropin-releasing hormone receptor","indications":["Advanced Prostatic Carcinoma"],"catalyst":""},{"name":"Injection of Filgrastim","genericName":"Injection of Filgrastim","slug":"injection-of-filgrastim","phase":"phase_2","mechanism":"Filgrastim stimulates the production of white blood cells, specifically neutrophils, to help the body fight infection.","indications":["Reducing the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive chemotherapy","Reducing the duration of neutropenia and the incidence of febrile neutropenia in patients receiving myelosuppressive chemotherapy"],"catalyst":""},{"name":"NP137 DL and RP2D","genericName":"NP137 DL and RP2D","slug":"np137-dl-and-rp2d","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pazopanib Oral Tablet [Votrient]","genericName":"Pazopanib Oral Tablet [Votrient]","slug":"pazopanib-oral-tablet-votrient","phase":"phase_3","mechanism":"Pazopanib is a tyrosine kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFRs), platelet-derived growth factor receptors (PDGFRs), and c-KIT.","indications":["Soft tissue sarcoma","Advanced renal cell carcinoma"],"catalyst":""},{"name":"Placebo of AFATINIB","genericName":"Placebo of AFATINIB","slug":"placebo-of-afatinib","phase":"phase_3","mechanism":"This is a placebo control arm and contains no active pharmaceutical ingredient.","indications":[],"catalyst":""},{"name":"VEC","genericName":"VEC","slug":"vec","phase":"marketed","mechanism":"VEC is a therapeutic cancer vaccine that stimulates the immune system to recognize and attack cancer cells expressing specific tumor-associated antigens.","indications":["Colorectal cancer (advanced or metastatic)"],"catalyst":""},{"name":"Vesanoid","genericName":"Vesanoid","slug":"vesanoid","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"cicaderma + simple hygiene rules","genericName":"cicaderma + simple hygiene rules","slug":"cicaderma-simple-hygiene-rules","phase":"phase_3","mechanism":"Cicaderma is a topical treatment that combines cicatricial and anti-inflammatory properties to promote wound healing and improve skin hydration.","indications":["Treatment of dry skin and wound healing"],"catalyst":""},{"name":"interruption of Glivec®","genericName":"interruption of Glivec®","slug":"interruption-of-glivec","phase":"phase_3","mechanism":"Glivec is a tyrosine kinase inhibitor that targets BCR-ABL, c-KIT, and PDGFR.","indications":["Chronic myeloid leukemia","Acute lymphoblastic leukemia"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE03cm9ENko0UWFINlNrTzRCRlEyQ3VkZUVJUWdCRHBJVWJIVzVFaTRscDZ5QWswMnJEQkc4THRaZm1rS1ViNmJVQ2F2cHNHQlVEV0x4RFZBTFNHc3lSX1pDaEZyeml1X25CMHlBNnlkaThpRE9pZGtLT3ZBWXY?oc=5","date":"2024-10-08","type":"deal","source":"pharmaphorum","summary":"AZ and Owkin partner on AI to speed up BRCA testing - pharmaphorum","headline":"AZ and Owkin partner on AI to speed up BRCA testing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNWGVzMDdDaDlMNGs2dEtHaWdHZXkyZlNMNnJTU1ZWNFhncUNpS1pvaVZqUFFUX3FJeVo1UkJGZE5tWkdMQU1CM1FBM3dRV3A0dE9hb1hmNjFTdkwzclpFUVM3ZFhBYkdjNWx6aTI4WDh6aXRsd1RjSERFYzdTbWd5UDJHbHZzenJWQzQxTERMelhhZ01nU3NPY0lKclFkUVpoOVhF?oc=5","date":"2022-10-27","type":"pipeline","source":"pharmaphorum","summary":"ESMO 2022 – PAOLA-1, ovarian cancer, and treatment innovation - pharmaphorum","headline":"ESMO 2022 – PAOLA-1, ovarian cancer, and treatment innovation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9aVVdfMThDdGZkM09uUFZHUlZpQWFqM1QzLU5TQWs1dUhvU1M5TW9uR0tWejB1UTNwX3lHUy1vUm1YSkFJLVo3c0R4ZEV6U29EekVieU9YVktPcnJ5MUsyOVNLX3c1M3N6MTJ5TFBaUTYyRGpxVUZSeG1OSzhUNEE?oc=5","date":"2020-11-06","type":"regulatory","source":"PharmaTimes","summary":"Lynparza scores two new EU approvals - PharmaTimes","headline":"Lynparza scores two new EU approvals","sentiment":"positive"}],"patents":[],"drugCount":16,"phaseCounts":{"phase_3":8,"phase_2":4,"phase_1":2,"marketed":2},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}